Stevanato Group (NYSE:STVN) Shares Gap Up – Here’s What Happened

Shares of Stevanato Group S.p.A. (NYSE:STVN) gapped up prior to trading on Thursday . The stock had previously closed at €17.33, but opened at €18.25. Stevanato Group shares last traded at €18.21, with a volume of 24,427 shares trading hands.

Wall Street Analyst Weigh In

STVN has been the subject of a number of recent analyst reports. Wall Street Zen cut Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Weiss Ratings cut Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 11th. Citigroup lowered their price target on Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research note on Thursday, March 5th. KeyCorp lowered their price target on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, March 5th. Finally, Morgan Stanley lowered their price target on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, March 6th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Stevanato Group presently has a consensus rating of “Hold”.

Stevanato Group Price Performance

The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.11 and a current ratio of 1.63. The company has a 50-day moving average of €15.57 and a 200-day moving average of €18.23. The firm has a market capitalization of $5.43 billion, a price-to-earnings ratio of 30.42, a price-to-earnings-growth ratio of 1.60 and a beta of 0.75.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The business had revenue of €273.57 million during the quarter. During the same period in the previous year, the company earned $0.10 EPS. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. As a group, research analysts anticipate that Stevanato Group S.p.A. will post 0.68 EPS for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

A number of large investors have recently bought and sold shares of the company. GW&K Investment Management LLC raised its stake in shares of Stevanato Group by 76.2% during the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after purchasing an additional 1,055 shares in the last quarter. Fifth Third Bancorp raised its stake in shares of Stevanato Group by 22.6% during the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after purchasing an additional 773 shares in the last quarter. State of Wyoming raised its stake in shares of Stevanato Group by 39,216.7% during the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after purchasing an additional 2,353 shares in the last quarter. Quantbot Technologies LP bought a new stake in shares of Stevanato Group during the 3rd quarter worth approximately $68,000. Finally, Van Berkom & Associates Inc. raised its stake in Stevanato Group by 50.6% in the 3rd quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock valued at $93,000 after acquiring an additional 1,215 shares during the period.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.